Back to Clinical Research

Retinal Vein Occlusion

Status: Currently enrolling

  • Allergan Comparing visual improvement and total number of intraocular injections in patients with macular edema following central retinal vein occlusion (CRVO) after initial treatment with Ozurdex or Avastin.

Status: Completed 

  • CRUISE Study of Lucentis injections in patients with macular edema secondary to central retinal vein occlusion (CRVO).
  • BRAVO Study of Lucentis injections in patients with macular edema secondary to branch retinal vein occlusion (BRVO).
  • SCORE Study of Triamcinolone injections in patients with macular edema associated with central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO)
Back to Clinical Research